See if your patient qualifies for Lilly PatientOne services.

To enroll in Lilly PatientOne services, your patients will need to meet some basic requirements.

For reimbursement assistance:

• A qualified Lilly Oncology drug must be administered in the United States
• Patient must have proof of permanent, legal residency in the United States or Puerto Rico

For co-pay assistance*:

• Patient must be 18 years or older
• Patient must have proof of residency in the United States or Puerto Rico
• Patient must be treated with ALIMTA^® (pemetrexed for injection), CYRAMZA^® (ramucirumab), ERBITUX^® (cetuximab), LARTRUVO^™ (olaratumab), or Portrazza^® (necitumumab) for an FDA-approved indication
• Patient must be commercially insured^†

This offer is invalid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program.

Lilly Cares Foundation, Inc.:

The Lilly Cares Foundation, Inc., a separate nonprofit organization, provides free Lilly medications to qualifying patients. For more information about Lilly Cares, please visit LillyCares.com

If you have questions about patient eligibility requirements, Lilly PatientOne program specialists are available Monday–Friday, 9 am–7 pm ET. Call 1-866-4PatOne (1-866-472-8663) and let us know what we can do to help.

* This offer is not valid with any other financial support program, discount, or incentive involving ALIMTA, CYRAMZA, ERBITUX, LARTRUVO, or Portrazza.

† This offer is invalid for patients whose prescription claims for ALIMTA, CYRAMZA, ERBITUX, LARTRUVO, or Portrazza are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medigap, CHAMPUS, DOD, VA, TRICARE, or any state patient, or pharmaceutical assistance program. Additional program restrictions apply. Please see full Terms and Conditions.